APRIL 18, 2023
bioAffinity Technologies President and CEO Maria Zannes will address the Austin/San Antonio chapter of the Association for Corporate Growth (ACG) at a luncheon event on Tuesday, April 25, 2023. ACG is a global community for middle-market dealmakers and business leaders who invest in growth companies.
bioAffinity Technologies addresses the urgent need for noninvasive, early-stage cancer diagnosis and targeted cancer treatment. Ms. Zannes founded the company in 2014. Its first product, CyPath® Lung, is an accurate, noninvasive and cost-effective test for early detection of lung cancer. Learn more about CyPath® Lung at https://cypath.precisionpath.us/cypath-patient/.
The AGC lunch will be at Fleming’s Prime Steakhouse at Quarry Market, 255 E. Basse Road in San Antonio. Additional information and registration for the event are available here.